LeonaBio (LONA) Profit After Tax (2019 - 2026)
LeonaBio's (LONA) quarterly Profit After Tax came in at -$32.9 million in Q1 2026, down 260.17% year-on-year from $20.6 million in Q1 2025, and up 60.25% on a QoQ basis from -$82.9 million in Q4 2025.
LeonaBio (LONA) Profit After Tax (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 8 years of Profit After Tax data on file, last reported at -$32.9 million in Q1 2026.
- On a quarterly basis, Profit After Tax fell 260.17% year-over-year to -$32.9 million in Q1 2026; TTM through Mar 2026 was -$129.4 million, a 63.07% decrease from a year earlier, with the FY2025 full-year figure at -$105.6 million, down 9.34% from the prior year.
- Profit After Tax for Q1 2026 stood at -$32.9 million, up from -$82.9 million in the prior quarter.
- Over the last five years, Profit After Tax for LONA reached as high as -$6.6 million in Q3 2025 and fell as low as -$82.9 million in Q4 2025.
- Historically, Profit After Tax has averaged -$26.3 million across 5 years, with a median of -$26.3 million in 2024.
- On a YoY basis, Profit After Tax climbed as much as 76.97% in 2025 and fell as far as 465.66% in 2025.
- Year by year, Profit After Tax stood at -$30.1 million in 2022, then gained by 14.79% to -$25.7 million in 2023, then jumped by 42.94% to -$14.7 million in 2024, then slumped by 465.66% to -$82.9 million in 2025, then jumped by 60.25% to -$32.9 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$32.9 million in Q1 2026, -$82.9 million in Q4 2025, and -$6.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -453.82 Mn |
| 10 | LeonaBio | 138.33 Mn | 70.65 Mn | - | -32.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.95 Mn |
| Dec 31, 2025 | -82.89 Mn |
| Sep 30, 2025 | -6.61 Mn |
| Jun 30, 2025 | -6.97 Mn |
| Mar 31, 2025 | -9.15 Mn |
| Dec 31, 2024 | -14.65 Mn |
| Sep 30, 2024 | -28.70 Mn |
| Jun 30, 2024 | -26.86 Mn |
| Mar 31, 2024 | -26.34 Mn |
| Dec 31, 2023 | -25.68 Mn |
| Sep 30, 2023 | -32.97 Mn |
| Jun 30, 2023 | -29.60 Mn |
| Mar 31, 2023 | -27.82 Mn |
| Dec 31, 2022 | -30.14 Mn |
| Sep 30, 2022 | -20.19 Mn |
| Jun 30, 2022 | -24.34 Mn |
| Mar 31, 2022 | -20.98 Mn |
| Dec 31, 2021 | -16.76 Mn |
| Sep 30, 2021 | -15.71 Mn |
| Jun 30, 2021 | -13.97 Mn |